SESSION TITLE: Airways 2
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Inspiratory capacity (IC), an indirect marker of lung hyperinflation, is associated with dyspnea and exercise tolerance in patients with COPD. We performed a post-hoc analysis of pooled data from two Phase IIIb studies of GFF MDI, a LAMA/LABA FDC of glycopyrrolate (GP) and formoterol fumarate (FF), delivered by metered-dose inhaler (MDI) using novel cosuspension technology, to assess the effect of GFF MDI on IC in patients with moderate-to-very-severe COPD.